David Roth

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 620 Memorial Drive, Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Roth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Chief Medical Officer Common Stock 0 $0 $0.22 Nov 18, 2024 Direct
Syros Pharmaceuticals, Inc. Chief Medical Officer Restricted Stock Units 0 $0 $2.09 Oct 31, 2024 Direct

Insider Reports Filed by David Roth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Nov 18, 2024 1 -$2.38K 4 Nov 20, 2024 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2024 3 -$14.2K 4 Nov 4, 2024 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Apr 3, 2024 1 -$51.7K 4 Apr 5, 2024 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2024 6 -$25K 4 Apr 2, 2024 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Dec 12, 2023 1 -$31.1K 4 Dec 14, 2023 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Dec 6, 2023 1 -$24.8K 4 Dec 8, 2023 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2023 3 -$14K 4 Nov 2, 2023 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Jul 31, 2023 1 -$29K 4 Aug 2, 2023 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2023 3 -$1.61K 4 Apr 4, 2023 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Oct 6, 2022 2 $0 4 Oct 11, 2022 Chief Medical Officer
ALLR Allarity Therapeutics, Inc. Jul 7, 2022 0 $0 3 Jul 11, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Apr 1, 2022 1 -$30.6K 4 Apr 4, 2022 Chief Medical Officer
SYRS Syros Pharmaceuticals, Inc. Feb 15, 2022 3 $0 4 Feb 17, 2022 Chief Medical Officer